All Comments by Hiroshi Mori

  1. ApoE polymorphism in Polish patients with Alzheimer's disease.
  2. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
  3. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase.
  4. Mutations in the transmembrane domain of APP altering gamma-secretase specificity.
  5. Variabilities in the distribution of neurofibrillary tangles in the anterior parahippocampal gyrus at initial stages of Alzheimer's disease.
  6. Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: relation to Alzheimer's disease.
  7. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.
  8. The presenilin 1 mutation (M146V) linked to familial Alzheimer's disease attenuates the neuronal differentiation of NTera 2 cells.
  9. Acute application of human amylin, unlike beta-amyloid peptides, kills undifferentiated PC12 cells by apoptosis.
  10. Lack of association between an intronic polymorphism in the presenilin-1 gene and sporadic late-onset Alzheimer disease in Polish patients.
  11. An region upstream of the gene promoter for the beta-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells.
  12. Human amyloid precursor-like protein 1--cDNA cloning, ectopic expression in COS-7 cells and identification of soluble forms in the cerebrospinal fluid.
  13. Multiple pathways of apoptosis in PC12 cells. CrmA inhibits apoptosis induced by beta-amyloid.
  14. No association detected between very-low-density lipoprotein receptor (VLDL-R) and late-onset Alzheimer's disease in Hong Kong Chinese.
  15. Evidence for presenilin-1 involvement in amyloid angiopathy in the Alzheimer's disease-affected brain.